5d 1m 3m 1y 5y 10y
There is research on this stock available only to PRO subscribers.
There are no Transcripts on LPTN.
PR Newswire (Tue, 8:00AM)
PR Newswire (Jan 22, 2014)
PR Newswire (Dec 12, 2013)
LPTN vs. ETF Alternatives
Lpath, Inc., is a biotechnology company focused on the discovery and development of lipidomic-based therapeutic antibodies. It has two product candidates that are currently in clinical development, and one in pre-clinical evaluation.